Mark E. McComb

Mark E. McComb

Auto-generated profile, based on publicly available information

Mark E. McComb

Center for Biomedical Mass Spectrometry, Boston University School of Medicine , Boston, Massachusetts 02118, United States

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 October 2009 in Analytical Chemistry
Verified
Journal Article
Closed access
VBVivek N. Bhatia
Vivek N. Bhatia
DPDavid H. Perlman
David H. Perlman
CCCatherine E Costello
Catherine E Costello
MMMark E. McComb
Mark E. McComb

1 October 2013 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
PDF file
NLNancy Leymarie
Nancy Leymarie
PGPaula J. Griffin
Paula J. Griffin
KJKaren Jonscher
Karen Jonscher
DKDaniel Kolarich
Daniel Kolarich
RORon Orlando
Ron Orlando
CZChunxia Zou
Chunxia Zou
One of the principal goals of glycoprotein research is to correlate glycan structure and function. Such correlation is necessary in order for one to understand the mechanisms whereby glycoprotein structure elaborates the functions of myriad proteins. The accurate comparison of glycoforms and quantification of glycosites are essential steps in this direction. Mass spectrometry has emerged as a powerful analytical technique in the field of glycoprotein characterization. Its sensitivity, high dynamic range, and mass accuracy provide both quantitative and sequence/structural information. As part of the 2012 ABRF Glycoprotein Research Group study, we explored the use of mass spectrometry and ancillary methodologies to characterize the glycoforms of two sources of human prostate specific antigen (PSA). PSA is used as a tumor marker for prostate cancer, with increasing blood levels used to distinguish between normal and cancer states. The glycans on PSA are believed to be biantennary N-linked, and it has been observed that prostate cancer tissues and cell lines contain more antennae than their benign counterparts. Thus, the ability to quantify differences in glycosylation associated with cancer has the potential to positively impact the use of PSA as a biomarker. We studied standard peptide-based proteomics/glycomics methodologies, including LC-MS/MS for peptide/glycopeptide sequencing and label-free approaches for differential quantification. We performed an interlaboratory study to determine the ability of different laboratories to correctly characterize the differences between glycoforms from two different sources using mass spectrometry methods. We used clustering analysis and ancillary statistical data treatment on the data sets submitted by participating laboratories to obtain a consensus of the glycoforms and abundances. The results demonstrate the relative strengths and weaknesses of top-down glycoproteomics, bottom-up glycoproteomics, and glycomics methods.

27 January 2014 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
JBJessica B. Behring
Jessica B. Behring
VKVikas Kumar
Vikas Kumar
SWStephen A. Whelan
Stephen A. Whelan
PCPratibha Chauhan
Pratibha Chauhan
DSDeborah A. Siwik
Deborah A. Siwik
MBMarkus M. Bachschmid
Markus M. Bachschmid
Using a novel cysteine thiol labeling strategy coupled with mass spectrometric analysis, we identified and quantified the changes in global reversible cysteine oxidation of proteins in the left ventricle of hearts from mice with metabolic syndrome‐associated diastolic dysfunction. This phenotype was induced by feeding a high‐fat, high‐sucrose, type‐2 diabetogenic diet to C57BL/6J mice for 8 mo. The extent of reversible thiol oxidation in relationship to the total available (free and reducible) level of each cysteine could be confidently determined for 173 proteins, of which 98 contained cysteines differentially modified ≥1.5‐fold by the diet. Our findings suggest that the metabolic syndrome leads to potentially deleterious changes in the oxidative modification of metabolically active proteins. These alterations may adversely regulate energy substrate flux through glycolysis, β‐oxidation, citric acid (TCA) cycle, and oxidative phosphorylation (oxphos), thereby contributing to maladaptive tissue remodeling that is associated with, and possibly contributing to, diastolic left ventricular dysfunction.—Behring, J. B., Kumar, V., Whelan, S. A., Chauhan, P., Siwik, D. A., Costello, C. E., Colucci, W. S., Cohen, R. A., McComb M. E., Bachschmid, M. M. Does reversible cysteine oxidation link the Western diet to cardiac dysfunction? FASEB J . 28, 1975–1987 (2014). www.fasebj.org

7 December 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CYChunxiang Yao
Chunxiang Yao
JBJessica B Behring
Jessica B Behring
DSDi Shao
Di Shao
Aaron SverdlovAaron Sverdlov
Aaron Sverdlov
SWStephen A Whelan
Stephen A Whelan
MBMarkus M Bachschmid
Markus M Bachschmid
Reactive protein cysteine thiolates are instrumental in redox regulation. Oxidants, such as hydrogen peroxide (H2O2), react with thiolates to form oxidative post-translational modifications, enabling physiological redox signaling. Cardiac disease and aging are associated with oxidative stress which can impair redox signaling by altering essential cysteine thiolates. We previously found that cardiac-specific overexpression of catalase (Cat), an enzyme that detoxifies excess H2O2, protected from oxidative stress and delayed cardiac aging in mice. Using redox proteomics and systems biology, we sought to identify the cysteines that could play a key role in cardiac disease and aging. With a ‘Tandem Mass Tag’ (TMT) labeling strategy and mass spectrometry, we investigated differential reversible cysteine oxidation in the cardiac proteome of wild type and Cat transgenic (Tg) mice. Reversible cysteine oxidation was measured as thiol occupancy, the ratio of total available versus reversibly oxidized cysteine thiols. Catalase overexpression globally decreased thiol occupancy by ≥1.3 fold in 82 proteins, including numerous mitochondrial and contractile proteins. Systems biology analysis assigned the majority of proteins with differentially modified thiols in Cat Tg mice to pathways of aging and cardiac disease, including cellular stress response, proteostasis, and apoptosis. In addition, Cat Tg mice exhibited diminished protein glutathione adducts and decreased H2O2 production from mitochondrial complex I and II, suggesting improved function of cardiac mitochondria. In conclusion, our data suggest that catalase may alleviate cardiac disease and aging by moderating global protein cysteine thiol oxidation.

17 June 2006 in Journal of Proteome Research
Verified
Journal Article
Closed access
CDClaire Dauly
Claire Dauly
DPDavid H. Perlman
David H. Perlman
CCCatherine E Costello
Catherine E Costello
MMMark E. McComb
Mark E. McComb

22 May 2015 in Journal of the American Society for Mass Spectrometry
Verified
Journal Article
Closed access
RTRoger Théberge
Roger Théberge
SDSergei Dikler
Sergei Dikler
CHChristian Heckendorf
Christian Heckendorf
DCDavid H. K. Chui
David H. K. Chui
CCCatherine E Costello
Catherine E Costello
MMMark E. McComb
Mark E. McComb